Alignment Healthcare Announces Pricing of Secondary Offering

Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) announced a public offering of 9,000,000 shares by selling stockholders at a price of $14.75 per share. The offering's proceeds will not benefit the company, as they will go to the selling stockholders. This underwritten public offering is scheduled to close on September 20, 2022, contingent on customary conditions. J.P. Morgan is the underwriter for this offering. This release also highlights the company's focus on delivering customized healthcare through its Medicare Advantage plans for seniors and the chronically ill.

Positive

• None

Negative

• Company will not receive proceeds from the public offering, which could indicate a lack of direct financial support.
• Potential dilution of shares due to the public offering could negatively impact existing shareholders.

ORANGE, Calif., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment Healthcare” or the “Company”), a tech-enabled Medicare Advantage company, today announced the pricing of its previously announced underwritten public offering of 9,000,000 shares of its common stock by certain selling stockholders. The underwriter sold the shares at a public offering price of $14.75 per share. The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholders. The offering is expected to close on September 20, 2022, subject to customary closing conditions.

J.P. Morgan is acting as the underwriter for the offering.

A shelf registration statement on Form S-3 (including a prospectus) relating to the securities being sold in the offering was deemed automatically effective upon filing with the Securities and Exchange Commission. A copy of the final prospectus, when available, may be obtained for free by visiting EDGAR on the SEC website at www.sec.gov, or by contacting: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone: 1-866-803-9204, or by email at prospectus-eq_fi@jpmchase.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Alignment Healthcare

Alignment Healthcare is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The company provides partners and patients with customized care and service where they need it and when they need it, including clinical coordination, risk management and technology enablement. Alignment Healthcare offers health plan options through Alignment Health Plan and also partners with select health plans to help deliver better benefits at lower costs.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include, among others, statements concerning the expected closing of the offering. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to attract new members and enter new markets, including the need for certain governmental approvals; our ability to maintain a high rating for our plans on the Five Star Quality Rating System; risks associated with being a government contractor; changes in laws and regulations applicable to our business model; changes in market or industry conditions and receptivity to our technology and services; results of litigation or a security incident; the impact of shortages of qualified personnel and related increases in our labor costs; and the impact of COVID-19 on our business and results of operation. There can be no assurance that Alignment Healthcare will be able to complete the offering on the anticipated terms, or at all. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our Annual Report on Form 10-K for the year ended December 31, 2021, and the other periodic reports we file with the SEC. All information provided in this release is as of the date hereof, and we undertake no duty to update or revise this information unless required by law.

Investor Contact
Harrison Zhuo
hzhuo@ahcusa.com

Media Contact
Maggie Habib
mPR, Inc. for Alignment Healthcare
alignment@mpublicrelations.com 

FAQ

What is the price of Alignment Healthcare's recent public offering?

The shares were priced at $14.75 each.

How many shares are being offered in Alignment Healthcare's public offering?

A total of 9,000,000 shares are being offered by certain selling stockholders.

When will the public offering for Alignment Healthcare close?

The offering is expected to close on September 20, 2022.

Who is the underwriter for Alignment Healthcare's public offering?

J.P. Morgan is acting as the underwriter for the offering.

Will Alignment Healthcare receive proceeds from the public offering?

No, the company will not receive any proceeds from the sale of the shares.